Incidence of left atrial thrombus prior to atrial fibrillation ablation: Is pre-procedural transoesophageal echocardiography mandatory?

Europace

Volumn 12, Issue 7, 2010, Pages 927-932

  Mccready, James W ^a   Nunn, Laurence ^a   Lambiase, Pier D ^a   Ahsan, Syed Y ^a   Segal, Oliver R ^a   Rowland, Edward ^a   Lowe, Martin D ^a   Chow, Anthony W ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anti coagulation; Atrial fibrillation; Fibrinolytic agents; Radiofrequency catheter ablation; Transoesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; ECHOGRAPHY; INCIDENCE; MIDDLE AGED; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TREATMENT OUTCOME; UNITED KINGDOM; UTILIZATION;

ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TREATMENT OUTCOME;

EID: 77954973969     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq074     Document Type: Article

References (25)

1. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-1105 (Pubitemid 40365469)
2. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007;9:335-379
3. Lesaka Y. Complications of catheter ablation of atrial fibrillation: Cause, prevention and management. J Cardiovasc Electrophysiol 2006;17:S50-5.
4. Bertaglia E, Zoppo F, Tondo C, Colella A, Mantovan R, Senatore G et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 2007;4:1265-1271
5. Bhargava M, Marrouche NF, Martin DO, Schweikert RA, Saliba W, Saad EB et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter. J Cardiovasc Electrophysiol 2004;15:8-13.
6. Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002;13: 764-767
7. Koca V, Bozat T, Akkaya V, Sarikamis C, Turk T, Vural H et al. Left atrial thrombus detection with multiplane transesophageal echocardiography: an echocardiographic study with surgical verification. J Heart Valve Dis 1999;8:63-66
8. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol 2006; 17:1-7.
9. Hill JN. Detection of thrombus before ablation for atrial fibrillation: focus determines reality. J Cardiovasc Electrophysiol 2008;19:359-361
10. Hwang JJ, Chen JJ, Lin SC, Tseng YZ, Kuan P, Lien WP et al. Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations. Am J Cardiol 1993;72:677-681
11. Schneider B, Stollberger C, Schneider B. Diagnosis of left atrial appendage thrombi by multiplane transesophageal echocardiography: interlaboratory comparative study. Circ J 2007;71:122-125
12. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457
13. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30:1223-1229
14. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992;116:1-5.
15. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998;158: 1316-1320
16. van Walraven C, Hart RG, Wells GA, Petersen P, Koudstaal PJ, Gullov AL et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003;163:936-943
17. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005;96: 935-941
18. Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007;28: 2217-2222
19. Khan MN, Usmani A, Noor S, Elayi S, Ching CK, Di Biase L et al. Low incidence of left atrial or left atrial appendage thrombus in patients with paroxysmal atrial fibrillation and normal EF who present for pulmonary vein antrum isolation procedure. J Cardiovasc Electrophysiol 2008;19:356-358
20. Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006;92:1259-1264
21. Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr, Tajik AJ. Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996;28:1226-1233
22. Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA et al. Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation. J Cardiovasc Electrophysiol 2009;20:379-384
23. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WHW, Gabriel RS et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009;54:2032-2039
24. Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age .75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J 2008;156:57-64.
25. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:301-307